Mannitol
Generic: MANNITOL
Basic Information
Manufacturer
Henry Schein, Inc.
Product Type
HUMAN PRESCRIPTION DRUG
Route of Administration
INTRAVENOUS
FDA Set ID
e2444db1-9dfe-451f-a33c-9b00786464d2
Indications & Usage
1 INDICATIONS AND USAGE Mannitol Injection is indicated for the reduction of: intracranial pressure and treatment of cerebral edema.
elevated intraocular pressure.
Mannitol Injection is an osmotic diuretic, indicated for the reduction of: intracranial pressure and treatment of cerebral edema.
(1) elevated intraocular pressure.
(1)
elevated intraocular pressure.
Mannitol Injection is an osmotic diuretic, indicated for the reduction of: intracranial pressure and treatment of cerebral edema.
(1) elevated intraocular pressure.
(1)
Adverse Reactions
6 ADVERSE REACTIONS The following adverse reactions associated with the use mannitol were identified in clinical studies or postmarketing reports.
Because some of these reactions were reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.
Most common adverse reactions are hypersensitivity reactions, renal failure, CNS toxicity, hypo/hypervolemia, hypo/hypernatremia, hypo/hyperkalemia, and infusion site reactions.
(6) To report SUSPECTED ADVERSE REACTIONS, contact Hospira, Inc.
at 1-800-441-4100 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Image1.jpg
Because some of these reactions were reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.
Most common adverse reactions are hypersensitivity reactions, renal failure, CNS toxicity, hypo/hypervolemia, hypo/hypernatremia, hypo/hyperkalemia, and infusion site reactions.
(6) To report SUSPECTED ADVERSE REACTIONS, contact Hospira, Inc.
at 1-800-441-4100 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Image1.jpg